These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23568537)

  • 1. Inverse metabolic engineering to improve Escherichia coli as an N-glycosylation host.
    Pandhal J; Woodruff LB; Jaffe S; Desai P; Ow SY; Noirel J; Gill RT; Wright PC
    Biotechnol Bioeng; 2013 Sep; 110(9):2482-93. PubMed ID: 23568537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli.
    Pandhal J; Desai P; Walpole C; Doroudi L; Malyshev D; Wright PC
    Biochem Biophys Res Commun; 2012 Mar; 419(3):472-6. PubMed ID: 22342719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse Metabolic Engineering for Enhanced Glycoprotein Production in Escherichia coli.
    Jaffé SR; Strutton B; Pandhal J; Wright PC
    Methods Mol Biol; 2015; 1321():17-35. PubMed ID: 26082212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring.
    Pandhal J; Ow SY; Noirel J; Wright PC
    Biotechnol Bioeng; 2011 Apr; 108(4):902-12. PubMed ID: 21404263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Producing a glycosylating Escherichia coli cell factory: The placement of the bacterial oligosaccharyl transferase pglB onto the genome.
    Strutton B; Jaffé SRP; Pandhal J; Wright PC
    Biochem Biophys Res Commun; 2018 Jan; 495(1):686-692. PubMed ID: 29113801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.
    Pratama F; Linton D; Dixon N
    Microb Cell Fact; 2021 Oct; 20(1):198. PubMed ID: 34649588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glycosylation efficiency of recombinant proteins in Escherichia coli by auto-induction.
    Ding N; Yang C; Sun S; Han L; Ruan Y; Guo L; Hu X; Zhang J
    Biochem Biophys Res Commun; 2017 Mar; 485(1):138-143. PubMed ID: 28188786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
    Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
    Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli as a glycoprotein production host: recent developments and challenges.
    Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
    Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Recombinant N-Linked Glycoproteins in E. coli.
    Strutton B; Jaffé SRP; Pandhal J; Wright PC
    Methods Mol Biol; 2017; 1586():233-250. PubMed ID: 28470609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving bioreactor production of a recombinant glycoprotein in Escherichia coli: Effect of specific growth rate on protein glycosylation and specific productivity.
    Caillava AJ; Ortiz GE; Melli LJ; Ugalde JE; Ciocchini AE; Comerci DJ
    Biotechnol Bioeng; 2019 Jun; 116(6):1427-1438. PubMed ID: 30739323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoenzymatic Fc glycosylation via engineered aldehyde tags.
    Smith EL; Giddens JP; Iavarone AT; Godula K; Wang LX; Bertozzi CR
    Bioconjug Chem; 2014 Apr; 25(4):788-95. PubMed ID: 24702330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inverse metabolic engineering approach for the design of an improved host platform for over-expression of recombinant proteins in Escherichia coli.
    Ghosh C; Gupta R; Mukherjee KJ
    Microb Cell Fact; 2012 Jul; 11():93. PubMed ID: 22759404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Linked glycoengineering for human therapeutic proteins in bacteria.
    Pandhal J; Wright PC
    Biotechnol Lett; 2010 Sep; 32(9):1189-98. PubMed ID: 20449632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a protein glycosylation operon from Campylobacter jejuni JCM 2013 and its heterologous expression in Escherichia coli.
    Srichaisupakit A; Ohashi T; Fujiyama K
    J Biosci Bioeng; 2014 Sep; 118(3):256-62. PubMed ID: 24650731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GlycoSNAP: A High-Throughput Screening Methodology for Engineering Designer Glycosylation Enzymes.
    Ollis AA; Chai Y; DeLisa MP
    Methods Mol Biol; 2015; 1321():37-47. PubMed ID: 26082213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of three N-acetylaminosugar-conjugated flavonoids using engineered Escherichia coli.
    Cho AR; Lee SJ; Kim BG; Ahn JH
    Microb Cell Fact; 2016 Oct; 15(1):182. PubMed ID: 27776529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli.
    Wacker M; Linton D; Hitchen PG; Nita-Lazar M; Haslam SM; North SJ; Panico M; Morris HR; Dell A; Wren BW; Aebi M
    Science; 2002 Nov; 298(5599):1790-3. PubMed ID: 12459590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry investigation of glycosylation on the NXS/T sites in recombinant glycoproteins.
    Sokolowska I; Ngounou Wetie AG; Roy U; Woods AG; Darie CC
    Biochim Biophys Acta; 2013 Aug; 1834(8):1474-83. PubMed ID: 23632316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.